These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9178204)
1. Novel approaches to the inhibition of cytokine responses in asthma. Higgs OA J Pharm Pharmacol; 1997 May; 49 Suppl 3():25-31. PubMed ID: 9178204 [No Abstract] [Full Text] [Related]
2. Agents against cytokine synthesis or receptors. Yamagata T; Ichinose M Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805 [TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of Petasites japonicus extract on ovalbumin-induced airway inflammation in an asthmatic mouse model. Lee JS; Yang EJ; Yun CY; Kim DH; Kim IS J Ethnopharmacol; 2011 Jan; 133(2):551-7. PubMed ID: 21029770 [TBL] [Abstract][Full Text] [Related]
4. Cytokine and anti-cytokine therapy for asthma. Simon HU Curr Allergy Asthma Rep; 2006 Mar; 6(2):117-21. PubMed ID: 16566861 [TBL] [Abstract][Full Text] [Related]
5. Cytokine antagonists for the treatment of asthma: progress to date. Antoniu SA BioDrugs; 2009; 23(4):241-51. PubMed ID: 19697966 [TBL] [Abstract][Full Text] [Related]
6. Targets for asthma therapy. Boushey H Allerg Immunol (Paris); 2000 Nov; 32(9):336-41. PubMed ID: 11195856 [TBL] [Abstract][Full Text] [Related]
10. [From mollusk to man: YKL-40, a novel mediator of severe asthma]. Pretolani M Med Sci (Paris); 2008 Mar; 24(3):235-7. PubMed ID: 18334164 [No Abstract] [Full Text] [Related]
11. Knowledge of inflammatory cytokines and mediators in asthma: what is its importance in clinical practice? Nardini S Monaldi Arch Chest Dis; 1997 Feb; 52(1):86-8. PubMed ID: 9151532 [No Abstract] [Full Text] [Related]
12. Altering the Th1/Th2 balance as a therapeutic strategy in asthmatic diseases. Ray A; Cohn L Curr Opin Investig Drugs; 2000 Dec; 1(4):442-8. PubMed ID: 11249697 [TBL] [Abstract][Full Text] [Related]
13. 18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model. Kim SH; Hong JH; Lee JE; Lee YC Environ Toxicol Pharmacol; 2017 Jun; 52():99-113. PubMed ID: 28410469 [TBL] [Abstract][Full Text] [Related]
15. Oleanolic acid suppresses ovalbumin-induced airway inflammation and Th2-mediated allergic asthma by modulating the transcription factors T-bet, GATA-3, RORγt and Foxp3 in asthmatic mice. Kim SH; Hong JH; Lee YC Int Immunopharmacol; 2014 Feb; 18(2):311-24. PubMed ID: 24374304 [TBL] [Abstract][Full Text] [Related]
16. Leukotriene antagonists in asthma. Lipworth B; Jackson C N Engl J Med; 2011 Jul; 365(3):272-3; author reply 273-4. PubMed ID: 21774722 [No Abstract] [Full Text] [Related]
17. Normalisation of MRI ventilation heterogeneity in severe asthma by dupilumab. Svenningsen S; Haider EA; Eddy RL; Parraga G; Nair P Thorax; 2019 Nov; 74(11):1087-1088. PubMed ID: 31285363 [No Abstract] [Full Text] [Related]
18. Effects of steroid therapy on inflammatory cell subtypes in asthma. Boulet LP Thorax; 2010 May; 65(5):374-6. PubMed ID: 20435856 [No Abstract] [Full Text] [Related]
19. 'Good' lipids for asthma. Peters-Golden M Nat Med; 2002 Sep; 8(9):931-2. PubMed ID: 12205450 [No Abstract] [Full Text] [Related]
20. Asthma: still a promising future? Chanez P; Humbert M Eur Respir Rev; 2014 Dec; 23(134):405-7. PubMed ID: 25445937 [No Abstract] [Full Text] [Related] [Next] [New Search]